Category: Alphabet

  • Alphabet’s Verily + L’Oréal Partner to Advance Precision Skin Health

    What You Should Know: – Today, Alphabet’s Verily, a world leader in personalized medicine, and L’Oréal, the world leader in beauty, joined forces to lead a new era of precision skin health. – The first-of-its-kind partnership in the beauty industry aims to break down barriers to dermatology care and bring new insights to dermatologists that […]

  • Alphabet’s DeepMind forms AI drug discovery unit Isomorphic Labs

    Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into DeepMind’s AI-powered AlphaFold engine that last year became the first to solve the tricky problem of predicting protein folding, but will operate separately. It […]

  • Strive Health Raises $140M for Value-Based Kidney Care Platform

    What You Should Know: – Strive Health, a Denver-based provider of value-based kidney care today announced $140 million in Series B funding with Alphabet’s independent growth fund, CapitalG, as the lead investor. Strive has more than doubled its presence in regional markets and grown its employee base by more than 600% in the last year. This funding will further increase that momentum.  […]

  • Verily and Janssen Launch COVID-19 Immune Response Study

    What You Should Know: – Verily and Janssen launches COVID-19 Immune Response Study that aims to collect detailed information about how the coronavirus affects the immune system immediately after someone tests positive for COVID-19. Verily, an Alphabet company, is partnering with Janssen Research & Development LLC (Janssen) to launch a COVID-19 Immune Response Study as […]

  • Google’s Verily eyes 2021 growth after £700m funding round

    Verily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors including its parent company, and Google holding firm, Alphabet. The capital injection will support wide-ranging plans for the new year that include several life sciences programmes in surgery, pathology and immunology, which would add to the digital […]

  • How Verily plans to use $700M in new funding

    Alphabet and other investors poured $700 million in funding into Verily last week. The company, which is Alphabet’s life sciences subsidiary, plans to pour some of the funds into supporting Covid-19 vaccine studies and programs for businesses.

  • Cityblock Health Reaches $1B Valuation, Raises $160M to Address Systemic Healthcare Inequity

    What You Should Know: – Cityblock Health, a transformative, value-based healthcare provider focused on improving healthcare outcomes for marginalized communities, today announced a $160M Series C round, bringing its total raised to $300M. – Cityblock is a care delivery trailblazer working to right the injustices of a healthcare system that cycles vulnerable communities through frequent […]

  • Lessons learned from Verily’s Covid-19 testing efforts

    Google’s sister company launched a program in California and other states to help route patients to nearby coronavirus testing. Dr. Vivian Lee, president of health platforms for Verily, shared lessons learned from that effort and Verily’s work with schools and businesses.

  • Verily launches stop-loss health insurance subsidiary

    Alphabet’s healthcare subsidiary, Verily, will partner with Swiss Re Corporate Solutions to create a new stop-loss insurance company. The new entity, called Coefficient, will use data analytics to help self-funded companies manage unexpected areas of cost.

  • Verily Forms New Subsidiary Focused on Employer Stop-Loss Through Precision Risk

    What You Should Know: – Alphabet’s Verily has established a new subsidiary, Coefficient, with a mission to create value by combining innovative health technology solutions with new insurance and payment models. Verily is the majority shareholder and Swiss Re Corporate Solutions, an established player in the employer stop-loss market, has a minority stake in the […]

  • Alphabet’s Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing

    Shots: Verily has expedite the COVID-19 testing with a new lab-based at South San Francisco. The lab will use the technology from Thermo Fisher Scientific’s‎ TaqPath test kit that has received the US FDA’s EUA to test COVID-19 Verily has submitted a EUA for an adaptation of the TaqPath test to use in testing pooled […]

  • Alphabet spinoff CityBlock Health raises $54 million

    CityBlock Health, a company building out healthcare services for low-income communities, raised $53.5 million in a series B extension. The company plans to use the funds to expand its clinical programs and further develop its technology.